Research programme: viral infections - DuPont/Signal
Alternative Names: Viral infections research programme - DuPont/SignalLatest Information Update: 07 Nov 2003
At a glance
- Originator DuPont; Signal Research Division
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C; HIV infections
Most Recent Events
- 31 Dec 2000 The agreement between DuPont and Signal has expired
- 31 Dec 2000 Discontinued - Preclinical for Hepatitis C in USA (unspecified route)
- 31 Dec 2000 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)